Revelation Biosciences, Inc.
- REVB
- NASDAQ
- Biotechnology
- Clinical-Stage Biopharma
- Immune-Modulating Therapies
- Immune Diagnostics
$0.48
Today −1.20%Quote Oct 19, 2026, 03:24 PM UTC
−48.98%over the last month
Max drawdown −50.5%From 1-month high −50.5%3 months −58.2%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$1.9M
Quote Oct 19
Next earnings
Nov 5
Expected, not confirmed
Latest analyst target
—
Data unavailable
Floor
—
Data unavailable
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about REVBPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
8